{"abstract":"The Food and Drug Administration (FDA) has determined that ALBAMYCIN (novobiocin sodium) capsule, 250 milligrams (mg) was withdrawn from sale for reasons of safety or effectiveness. The Agency will not accept or approve abbreviated new drug applications (ANDAs) for ALBAMYCIN (novobiocin sodium) capsule, 250 mg.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2011/01/19/2011-1000.html","cfr_references":[],"citation":"76 FR 3143","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket No. FDA-2008-P-0431"],"dockets":[],"document_number":"2011-1000","effective_on":null,"end_page":3144,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2011/01/19/2011-1000.xml","html_url":"https://www.federalregister.gov/documents/2011/01/19/2011-1000/determination-that-albamycin-novobiocin-sodium-capsule-250-milligrams-was-withdrawn-from-sale-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2011-1000?publication_date=2011-01-19","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2011-01-19/2011-1000/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":3902,"last_updated":"2026-07-26 18:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2011-01-19/pdf/2011-1000.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2011-01-19","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2011/01/19/2011-1000.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2011-02-08T08:36:39Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":3143,"subtype":null,"title":"Determination That ALBAMYCIN (Novobiocin Sodium) Capsule, 250 Milligrams, Was Withdrawn From Sale for Reasons of Safety or Effectiveness","toc_doc":"ALBAMYCIN (Novobiocin Sodium) Capsule, 250 Milligrams","toc_subject":"Determination that Product Was Withdrawn From Sale for Reasons of Safety or Effectiveness:","topics":[],"type":"Notice","volume":76}